Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, Zenas BioPharma is raising $183,898,435.00 in new funding. Sources indicate as part of senior management President, Joseph Farmer played a key role…
Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, Orionis Biosciences is raising $55,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Nikolai Kley…
Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, Hawthorne Food dba Eastern Standard Provisions is raising $2,300,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer,…
Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, Finwave Semiconductor is raising $15,499,987.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Bin Lu played a…
Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, PaymentWorks is raising $17,000,000.00 in new funding. Sources indicate as part of senior management President, Thayer Stewart played a key role in…
Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, Amagma is raising $2,275,888.00 in new funding. Sources indicate as part of senior management President, Tillman Gerngross played a key role in…
Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, Eleanor Health is raising $78,578,952.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Corbin Petro played a…
Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, OncXerna Therapeutics is raising $100,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Laura Benjamin played a…
Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, Third Pole is raising $39,901,424.00 in new funding. Sources indicate as part of senior management President, Basil Athenson played a key role…
Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, Ventus Therapeutics is raising $139,999,982.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, ZacK Mcnealy played a…